NCT01642550View on ClinicalTrials.gov

Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Anorexia Nervosa
Interventions
DRUG

RM-131

RM-131 (100 mcg) will be administered daily by subcutaneous injection for 28 days.

DRUG

Placebo

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
lead

Motus Therapeutics, Inc.

INDUSTRY

NCT01642550 - Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa | Biotech Hunter | Biotech Hunter